240 related articles for article (PubMed ID: 19461430)
1. Antenatal magnesium sulfate and neurologic outcome in preterm infants: a systematic review.
Doyle LW; Crowther CA; Middleton P; Marret S
Obstet Gynecol; 2009 Jun; 113(6):1327-1333. PubMed ID: 19461430
[TBL] [Abstract][Full Text] [Related]
2. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus.
Doyle LW; Crowther CA; Middleton P; Marret S
Cochrane Database Syst Rev; 2007 Jul; (3):CD004661. PubMed ID: 17636771
[TBL] [Abstract][Full Text] [Related]
3. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus.
Doyle LW; Crowther CA; Middleton P; Marret S; Rouse D
Cochrane Database Syst Rev; 2009 Jan; (1):CD004661. PubMed ID: 19160238
[TBL] [Abstract][Full Text] [Related]
4. Effect of magnesium sulfate given for neuroprotection before preterm birth: a randomized controlled trial.
Crowther CA; Hiller JE; Doyle LW; Haslam RR;
JAMA; 2003 Nov; 290(20):2669-76. PubMed ID: 14645308
[TBL] [Abstract][Full Text] [Related]
5. Assessing the neuroprotective benefits for babies of antenatal magnesium sulphate: An individual participant data meta-analysis.
Crowther CA; Middleton PF; Voysey M; Askie L; Duley L; Pryde PG; Marret S; Doyle LW;
PLoS Med; 2017 Oct; 14(10):e1002398. PubMed ID: 28976987
[TBL] [Abstract][Full Text] [Related]
6. Effects of antenatal exposure to magnesium sulfate on neuroprotection and mortality in preterm infants: a meta-analysis.
Costantine MM; Weiner SJ;
Obstet Gynecol; 2009 Aug; 114(2 Pt 1):354-364. PubMed ID: 19622997
[TBL] [Abstract][Full Text] [Related]
7. Antenatal magnesium sulfate and neuroprotection.
Doyle LW
Curr Opin Pediatr; 2012 Apr; 24(2):154-9. PubMed ID: 22227787
[TBL] [Abstract][Full Text] [Related]
8. No. 376-Magnesium Sulphate for Fetal Neuroprotection.
Magee LA; De Silva DA; Sawchuck D; Synnes A; von Dadelszen P
J Obstet Gynaecol Can; 2019 Apr; 41(4):505-522. PubMed ID: 30879485
[TBL] [Abstract][Full Text] [Related]
9. SOGC Clinical Practice Guideline. Magnesium sulphate for fetal neuroprotection.
Magee L; Sawchuck D; Synnes A; von Dadelszen P; ;
J Obstet Gynaecol Can; 2011 May; 33(5):516-529. PubMed ID: 21639972
[TBL] [Abstract][Full Text] [Related]
10. Magnesium sulphate for women at term for neuroprotection of the fetus.
Nguyen TM; Crowther CA; Wilkinson D; Bain E
Cochrane Database Syst Rev; 2013 Feb; (2):CD009395. PubMed ID: 23450601
[TBL] [Abstract][Full Text] [Related]
11. Antenatal magnesium sulfate for the prevention of cerebral palsy in preterm infants less than 34 weeks' gestation: a systematic review and metaanalysis.
Conde-Agudelo A; Romero R
Am J Obstet Gynecol; 2009 Jun; 200(6):595-609. PubMed ID: 19482113
[TBL] [Abstract][Full Text] [Related]
12. [Neuroprotection for preterm infants with antenatal magnesium sulphate].
Marret S; Ancel PY
J Gynecol Obstet Biol Reprod (Paris); 2016 Dec; 45(10):1418-1433. PubMed ID: 28166926
[TBL] [Abstract][Full Text] [Related]
13. School-age outcomes of very preterm infants after antenatal treatment with magnesium sulfate vs placebo.
Doyle LW; Anderson PJ; Haslam R; Lee KJ; Crowther C;
JAMA; 2014 Sep; 312(11):1105-13. PubMed ID: 25226476
[TBL] [Abstract][Full Text] [Related]
14. [Prevention of cerebral palsy using magnesium sulfate in pre-term newborns].
Marret S; Chollat C; Levèque C; Marpeau L
Arch Pediatr; 2011 Mar; 18(3):324-30. PubMed ID: 21257296
[TBL] [Abstract][Full Text] [Related]
15. [Effect of magnesium sulphate on mortality and neurologic morbidity of the very-preterm newborn (of less than 33 weeks) with two-year neurological outcome: results of the prospective PREMAG trial].
Marret S; Marpeau L; Follet-Bouhamed C; Cambonie G; Astruc D; Delaporte B; Bruel H; Guillois B; Pinquier D; Zupan-Simunek V; Bénichou J;
Gynecol Obstet Fertil; 2008 Mar; 36(3):278-88. PubMed ID: 18337147
[TBL] [Abstract][Full Text] [Related]
16. Antenatal magnesium sulphate neuroprotection in the preterm infant.
Marret S; Doyle LW; Crowther CA; Middleton P
Semin Fetal Neonatal Med; 2007 Aug; 12(4):311-7. PubMed ID: 17513184
[TBL] [Abstract][Full Text] [Related]
17. Magnesium sulphate for preventing preterm birth in threatened preterm labour.
Crowther CA; Hiller JE; Doyle LW
Cochrane Database Syst Rev; 2002; (4):CD001060. PubMed ID: 12519550
[TBL] [Abstract][Full Text] [Related]
18. Antenatal exposure to magnesium sulfate and neuroprotection in preterm infants.
Costantine MM; Drever N
Obstet Gynecol Clin North Am; 2011 Jun; 38(2):351-66, xi. PubMed ID: 21575805
[TBL] [Abstract][Full Text] [Related]
19. Influence of antenatal magnesium sulfate application on cord blood levels of brain-derived neurotrophic factor in premature infants.
Bachnas MA; Mose JC; Effendi JS; Andonotopo W
J Perinat Med; 2014 Jan; 42(1):129-34. PubMed ID: 24062546
[TBL] [Abstract][Full Text] [Related]
20. Magnesium sulphate for fetal neuroprotection at imminent risk for preterm delivery: a systematic review with meta-analysis and trial sequential analysis.
Wolf HT; Huusom LD; Henriksen TB; Hegaard HK; Brok J; Pinborg A
BJOG; 2020 Sep; 127(10):1180-1188. PubMed ID: 32237069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
